Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$119.27 -0.7 | -0.58%
02/27/15 - 03:51 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 580.42M 1.21B 1.53B 1.41B
Cost of Sales 60.99M 81.91M 241.69M 27.06M
Gross Operating Profit 519.43M 1.13B 1.29B 1.38B
Selling, General, and Administrative Expenses 305.41M 362.34M 436.80M 400.72M
Research & Development 855.51M 918.78M 806.18M 707.71M
Operating Income before D & A (EBITDA) -641.49M -151.06M 42.37M 275.14M
Depreciation & Amortization 63.26M 48.36M 38.19M 53.45M
Interest Income 0.00 0.00 1.94M 1.88M
Other Income - Net 30.40M -49.94M 0.00 -16.80M
Special Income / Charges 0.00 -663.50M 0.00 -105.80M
Total Income Before Interest Expenses (EBIT) -725.27M -953.39M 4.27M 98.90M
Interest Expense 72.86M 22.73M 16.65M 38.45M
Pre-Tax Income -798.13M -976.12M -12.38M 60.44M
Income Taxes 6.96M -288.57M 38.75M 19.27M
Minority Interest -4.19M -242.52M 55.90M 11.60M
Net Income From Continuing Operations -741.83M -687.55M -51.14M 41.18M
Net Income From Discontinued Operations -912.00K 0.00 0.00 0.00
Net Income From Total Operations -742.74M -687.55M -51.14M 41.18M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -738.56M -445.03M -107.03M 29.57M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-690.91M 16.47M -49.29M 149.05M
Preferred Dividends
Net Income Available To Common -741.83M -687.55M -51.14M 41.18M
Basic EPS from Continuing Ops. -3.14 -1.98 -0.50 0.14
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -3.14 -1.98 -0.50 0.14
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -3.14 -1.98 -0.50 0.14
Basic Normalized Net Income/Share -2.92 0.05 -0.49 0.52
EPS fr Continuing Ops. -3.14 -1.98 -0.50 0.14
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -3.14 -1.98 -0.50 0.14
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -3.14 -1.98 -0.50 0.14
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.92 0.05 -0.49 0.51
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter